Therefore, a specific BAFF-blocking agent might be more advantageous, as agents blocking both BAFF and APRIL could disrupt B cell production of neutralizing anti-IgM antibodies, potentially increasing susceptibility to infections (24, 195, 196). This evidence concerns the gene TNFSF13B and infection.